BRIEF-TFF Pharmaceuticals Files For Offering Of Up To 2.6 Mln Shares Of Common Stock, Together With Series B Common Stock Purchase Warrants

Reuters04-29

April 29 (Reuters) - TFF Pharmaceuticals Inc :

* TFF PHARMACEUTICALS FILES FOR OFFERING OF UP TO 2.6 MILLION SHARES OF COMMON STOCK, TOGETHER WITH SERIES B COMMON STOCK PURCHASE WARRANTS

* TFF PHARMACEUTICALS INC - ASSUMED PUBLIC OFFERING PRICE FOR EACH SHARE OF COMMON STOCK AND ACCOMPANYING SERIES B WARRANT IS $3.05

Further company coverage:

(Reuters.Briefs@thomsonreuters.com)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2431856754?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-04-29 20:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2431856754","market":"us","top_or_hot":-1,"title":"BRIEF-TFF Pharmaceuticals Files For Offering Of Up To 2.6 Mln Shares Of Common Stock, Together With Series B Common Stock Purchase Warrants","media":"Reuters","content":"<html><body><p>April 29 (Reuters) - <a href=\"https://laohu8.com/S/TFFP\">TFF Pharmaceuticals</a> Inc   :</p><p>   * TFF PHARMACEUTICALS FILES FOR OFFERING OF UP TO 2.6 MILLION SHARES OF COMMON STOCK, TOGETHER WITH SERIES B COMMON STOCK PURCHASE WARRANTS</p><p>   * TFF PHARMACEUTICALS INC - ASSUMED PUBLIC OFFERING PRICE FOR EACH SHARE OF COMMON STOCK AND ACCOMPANYING SERIES B WARRANT IS $3.05</p><p>Further company coverage:   </p><p> (Reuters.Briefs@thomsonreuters.com)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-TFF Pharmaceuticals Files For Offering Of Up To 2.6 Mln Shares Of Common Stock, Together With Series B Common Stock Purchase Warrants</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-TFF Pharmaceuticals Files For Offering Of Up To 2.6 Mln Shares Of Common Stock, Together With Series B Common Stock Purchase Warrants\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-29 20:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>April 29 (Reuters) - TFF Pharmaceuticals Inc   :   * TFF PHARMACEUTICALS FILES FOR OFFERING OF UP TO 2.6 MILLION SHARES OF COMMON STOCK, TOGETHER WITH SERIES B COMMON STOCK PURCHASE WARRANTS   * TFF ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2431856754","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2431856754","pubTimestamp":1714392690,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"April 29  - TFF Pharmaceuticals Inc   :   * TFF PHARMACEUTICALS FILES FOR OFFERING OF UP TO 2.6 MILLION SHARES OF COMMON STOCK, TOGETHER WITH SERIES B COMMON STOCK PURCHASE WARRANTS   * TFF PHARMACEUTICALS INC - ASSUMED PUBLIC OFFERING PRICE FOR EACH SHARE OF COMMON STOCK AND ACCOMPANYING SERIES B WARRANT IS $3.05Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","TFFP":"TFF Pharmaceuticals"},"translate_title":"简报-TFF制药公司申请发行260万股普通股，以及B系列普通股认股权证","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TFFP":1},"content_text":"April 29 (Reuters) - TFF Pharmaceuticals Inc   :   * TFF PHARMACEUTICALS FILES FOR OFFERING OF UP TO 2.6 MILLION SHARES OF COMMON STOCK, TOGETHER WITH SERIES B COMMON STOCK PURCHASE WARRANTS   * TFF PHARMACEUTICALS INC - ASSUMED PUBLIC OFFERING PRICE FOR EACH SHARE OF COMMON STOCK AND ACCOMPANYING SERIES B WARRANT IS $3.05Further company coverage:    (Reuters.Briefs@thomsonreuters.com)","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2431856754"}